2021-06-27 01:10
Editas 今年底或者最晚明年初要出数据的,成年人中剂量组都已经完成了。
The IDMC endorsement is based on an analysis of safety data from the adult low-dose and adult mid-dose cohorts. The Company also announced the completion of dosing of the adult mid-dose cohort.
体内CRISPR基因编辑第一次临床试验大获成功,取得了比预想还要好得多的结果!
0.3mg/kg 低剂量组即让头三位病人的TTR分别下降了80%,84%,96%。
没有任何AE!
Editas 今年底或者最晚明年初要出数据的,成年人中剂量组都已经完成了。
The IDMC endorsement is based on an analysis of safety data from the adult low-dose and adult mid-dose cohorts. The Company also announced the completion of dosing of the adult mid-dose cohort.